These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7042538)

  • 1. Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.
    Jansen FK; Blythman HE; Carrière D; Casellas P; Gros O; Gros P; Laurent JC; Paolucci F; Pau B; Poncelet P; Richer G; Vidal H; Voisin GA
    Immunol Rev; 1982; 62():185-216. PubMed ID: 7042538
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.
    Vitetta ES; Krolick KA; Uhr JW
    Immunol Rev; 1982; 62():159-83. PubMed ID: 7042537
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.
    Bjorn MJ; Villemez CL
    Cancer Treat Res; 1988; 37():255-77. PubMed ID: 2908629
    [No Abstract]   [Full Text] [Related]  

  • 4. The preparation and cytotoxic properties of antibody-toxin conjugates.
    Thorpe PE; Ross WC
    Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536
    [No Abstract]   [Full Text] [Related]  

  • 5. A monoclonal immunotoxin against laryngeal carcinoma cells.
    Zenner HP
    Otolaryngol Pol; 1990; 44(3):214-5. PubMed ID: 2255554
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotoxins].
    Jansen FK; Blythman HE; Carrière D; Casellas P; Dussossoy D; Gros O; Gros P; Laurent JC; Paolucci F; Pau B; Poncelet P; Richer G; Vidal H; Voisin GA
    Bull Cancer; 1983; 70(3):165-8. PubMed ID: 6882931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody targeting of anti-cancer agents.
    Baldwin RW; Byers VS
    Springer Semin Immunopathol; 1986; 9(1):39-50. PubMed ID: 2425442
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to tumor antigens.
    Hellström KE; Brown JP; Hellström I
    Contemp Top Immunobiol; 1980; 11():117-37. PubMed ID: 6160947
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 12. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
    Vrionis FD; Wikstrand CJ; Bigner DD
    Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding and cytotoxic effect of ricin toxin on multivalent hybrid antibody-coated target cells.
    Laky M; Mota G; Moraru I; Ghetie V
    Immunol Lett; 1987 Jan; 14(2):127-32. PubMed ID: 3495487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxin therapy of malignancy.
    Grossbard ML; Nadler LM
    Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
    [No Abstract]   [Full Text] [Related]  

  • 15. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.
    Andrews PW; Banting G; Damjanov I; Arnaud D; Avner P
    Hybridoma; 1984; 3(4):347-61. PubMed ID: 6396197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of expression of surface antigen p72 using monoclonal antibody 79IT/36 and the effect of ricin A chain-bound 79IT/36 on phytohemagglutinin-stimulated human lymphocytes].
    Rytwiński K
    Acta Haematol Pol; 1989; 20(1):47-57. PubMed ID: 2618566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Receptors on Cancer Cells with Protein Toxins.
    Antignani A; Ho ECH; Bilotta MT; Qiu R; Sarnvosky R; FitzGerald DJ
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32957689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
    Ferrini S; Sforzini S; Canevari S
    Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
    [No Abstract]   [Full Text] [Related]  

  • 19. Human monoclonal antibodies to human leukemias. Initial characterization of specificities and antigens.
    Posner MR; Santos DJ; Elboim HS; Frackelton AR
    Prog Clin Biol Res; 1989; 288():95-9. PubMed ID: 2717644
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.